To the best of our knowledge, this is the first report in which CEC and CEP were simultaneously quantified and, at the same time, the CEC were characterized for the expression of the activation (CD62E, CD54) and procoagulant (CD142) molecules in patients with VTE and MPN. The gene discussed is ICAM1; the disease is myeloproliferative neoplasm.